Allarity Therapeutics, Inc. (ALLR): Capital Expenditures
$8.0K
Year ended 2025-12-31
$72.0K
Trailing 12 months to 2026-06-30
-23.7%
3-year compound annual growth
+21.7%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $8.0K | -97.3% | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | $298.0K | n/a | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | $0 | -100.0% | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | $18.0K | n/a | 2024-03-08, From 2022-01-01 |
| No annual figure between 2020-12-31 and 2022-12-31. | |||
| 2020-12-31 | $3.0K | n/a | 2022-05-17, From 2020-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $8.0K | -97.3% |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | $2.0K | -60.0% |
| Medicinova Inc (MNOV) | 2025-12-31 | $2.9K | +223.9% |
| Scienture Holdings, Inc. (SCNX) | 2024-12-31 | $12.0K | n/a |
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | $20.0K | n/a |
| Clene Inc. (CLNN) | 2025-12-31 | $39.0K | +160.0% |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $1.2K | -98.8% |
| Silence Therapeutics plc (SLN) | 2025-12-31 | $55.0K | -73.9% |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | $0 | -100.0% |
Compare ALLR, CANF, MNOV, SCNX side by side · Screen every company in Pharmaceutical Preparations ↗